Buying MDMA pills Aktobe

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Buying MDMA pills Aktobe

The main goal of the forum is to preserve the institutional memory of measures to comprehensively overcome pandemic threats using the example of COVID coronavirus infections, to popularize the effective activities of state and other bodies and scientific organizations in ensuring biological safety during a pandemic. The program announced the participation of the first heads of a number of state bodies, deputies of Parliament, representatives of international organizations, leading scientists, prominent public figures and business representatives. During the event, speakers and participants discussed the experience of Kazakhstan in combating the COVID pandemic, mechanisms and strategies in the prevention and prediction of biological threats , advanced technologies for the development of new drugs and agents against COVID to ensure biological safety. The lessons of the pandemic. The global pandemic has shown that the most important thing under any circumstances is a prompt response and the clear adoption of specific measures. For example, since the beginning of the epidemic, the Republican and operational headquarters have been established under the Ministry of Health and at the akimats of the regions, the cities of Almaty, Astana, Shymkent, which daily coordinated the work of medical organizations to combat coronavirus infection. In addition, from the first days of the announcement of the pandemic in Kazakhstan, an interdepartmental commission was created, which made decisions on the protection and protection of public health from COVID, the interaction of state bodies, strengthening the infrastructure of medical organizations, the purchase of medicines, immunobiological preparations, medical products and equipment. A single distributor, as an operator for the purchase and delivery of medicines within the framework of free drug provision for the whole country, played an important role during the pandemic in Kazakhstan. Providing the population with the necessary drugs, systematic work was carried out to improve work and increase efficiency. The main lesson of the pandemic was the formation of its own production, which ensures drug safety and stability in the country. The measure of support in the pharmaceutical industry is provided in the form of long-term contracts. To date, there are 99 such long-term contracts concluded between 36 domestic producers and the Single Distributor for the supply of more than 4. In this case, it is expedient to attract global BigPharma players to the Kazakhstani market. Leading companies such as Canon, Philips, General Electric, Samsung Medison, Mindray and others have expressed interest in localizing production. During his speech, Erkhat Serikovich dwelled on the development of the country's cluster initiative. By order of the Ministry of Health of the Republic of Kazakhstan, medical and pharmaceutical clusters will appear in the cities of Astana, Aktobe and Shymkent, due to the concentration of production sites and medical universities. Currently, work is underway to develop and approve road maps. The warehouse logistics of the Single Distributor did not go unnoticed either. The logistics system is built in such a way that the volumes of medicines and medical devices are distributed from 4 distribution HUBs to operational warehouses in the regions. HUBs are designed to receive a large volume of goods and store from 2 to 6 monthly needs for the regions. During the pandemic, having identified the weaknesses of the system, the company's logistics processes were modernized and the logistics of medicines were improved. Thus, the logistics format has changed from static to dynamic. An agreement was reached with airlines to speed up the delivery of drugs and the Kazlogistics Union, in case of an increase in refrigerated trucks. In total, about 10 speakers spoke at the forum, who voiced a number of topics: the Kazakh model of combating COVID, coronavirus in the United States: countermeasures and ways of stabilization, experience in applying evidence-based approaches to patient management during a pandemic, and others. After all the presentations, the Forum's resolution was adopted and priority areas were identified for preventing biological risks in modern conditions. At the end of the event, the participants of the dialogue platform voiced their readiness to take concrete steps to develop the industry within their competence, noting that such meetings play an important role in making certain management decisions and achieving national goals. In his Address to the people of Kazakhstan 'The unity of the people and systemic reforms are a solid foundation for the country's prosperity' on September 1, , the Head of State K. Tokayev noted the need to create a national system for predicting the country's biological safety and developing domestic biopharmaceutics. QazBioPharm National Holding JSC was established in order to ensure biological safety, sustainable development and improvement of the infrastructure of the biopharmaceutical market, stimulate the development of biopharmaceutical science and industry, as well as meet the needs of the state and society in biopharmaceutical products. Reference: In his Address to the people of Kazakhstan 'The unity of the people and systemic reforms are a solid foundation for the country's prosperity' on September 1, , the Head of State K. Back to news page. Contact center. Free of charge for all numbers. Public control. Acting Chairman's blog. Photo gallery. To see more.

OWN PHARMACEUTICAL PRODUCTION AS A GUARANTEE OF THE COUNTRY'S DRUG SAFETY

Buying MDMA pills Aktobe

On August 4, a regular meeting of the public working group under the Single Distributor SK-Pharmacy LLP was held, which includes representatives of civil society and the business community, deputies and industry experts. On the agenda, social activists touched upon a number of topical issues in the activities of the Single Distributor. In particular, potential risks were assessed in regulatory legal acts and in organizational and managerial activities, as well as in the field of rules for organizing and conducting the purchase of medicines. The main goal of the internal analysis of corruption risks is the elimination or minimization of corruption risks in the activities of the Single Distributor, especially in the regulatory legal acts relating to the activities of the Single Distributor, and in organizational and managerial activities. Members of the public working group were given the opportunity to submit proposals on their part to eliminate corruption risks. The single distributor carries out all the necessary anti-corruption measures provided for by the Concept, which is the direction of the implementation of the National Action Plan for the implementation of the Message of the Head of State. Thus, an internal analysis of corruption risks is carried out, an anti-corruption culture is being formed, and an anti-corruption management system is being maintained. An important point in the entire process of medical supply is the planning and development of applications by medical organizations. Recall that medical organizations themselves determine their need for the names of medicines, volumes and delivery schedule. The purchase and supply of drugs by the Single Distributor is carried out on the basis of these applications. The single distributor informed about the start of the application campaign for , the country's medical institutions have already begun to form their forecast needs for the coming year. Applications within the hospital by the regions have been formed, at the outpatient level, an application is expected in the near future from the Social Health Insurance Fund. As you know, the Single Distributor purchases in advance, that is, medicines for the next year are purchased already in the current year. The main conditions for the purchase of medicines are the delivery schedule. Procurement procedures are carried out in time to ensure the availability of medicines in the warehouses of the Single Distributor in December. Shipment to polyclinics and hospitals will begin in January A problematic aspect is the receivables of medical organizations. A single distributor annually receives less timely payment for the volume of medicines supplied to medical organizations, which negatively affects the further development of the country's medical supply system. A separate topic for discussion was the work with BigPharma. During the presentation, public figures were given more details about the work done to attract global players to the domestic pharmaceutical market. The head of state noted the importance of developing the domestic pharmaceutical market and cooperation with global pharmaceutical corporations, attracting investors, ensuring the transfer of technologies and the latest developments. In this vein, the key tool is cooperation with BigPharma companies and localization of production in Kazakhstan. To attract the production of branded drugs in the Republic of Kazakhstan, measures are envisaged to simplify the procedures for localizing production, taking into account all cycles, from packaging to deep localization. A single distributor systematically studies the best practices in the procurement and logistics of drugs from global players for its introduction to the domestic market. The issue of localizing the production of medicines and medical devices of BigPharma players on the basis of Kazakhstani manufacturers with the possibility of exporting to the countries of the EAEU and Central Asia is being worked out. Along with this, agreements were signed on the localization of production and technology transfer between domestic manufacturers and South Korean companies. Work is underway to sign an agreement on cooperation and readiness for localization with Bayer Germany , Takeda Japan , Novartis Switzerland and Janssen Belgium. Priority should be given to industries that meet international standards and provide an integrated approach to improving the product range with an emphasis on scientific and technological innovations, providing highly qualified personnel and maximizing the use of the country's intellectual potential, as well as promoting high-tech domestic products to foreign markets. Another important area, according to the Comprehensive Plan for the Development of the Pharmaceutical Industry until adopted by the Government, is the development of pharmaceutical science and the creation of new industries with the participation of world players. In this vein, the Single Distributor, based on the results of studying international experience, took the initiative to create medical and pharmaceutical clusters in the country. This will contribute to the creation of a favorable infrastructure for the development of the domestic pharmaceutical industry. To date, the relevant order to create medical and pharmaceutical clusters in the country in the cities of Astana, Aktobe and Shymkent has already entered into force and work is underway to develop and approve road maps for the implementation of the initiative. With such an integrated approach, in the future it will be possible to solve not only the current problems of the development of the pharmaceutical industry, but also to export new drugs and ensure the confidence of citizens in Kazakhstani drugs. The final presentation by the participants of the meeting was heard on the topic of centralized procurement of medical equipment for As you know, earlier the President instructed to switch to a centralized purchase of medical equipment on the basis of a single distributor, which is being implemented in stages. In pursuance of the instructions of the Head of State, systematic work has been done in terms of regulatory support, involvement of experts in medical equipment and automation of procurement mechanisms. Today, stage II activities are being carried out - this is personnel training, measures for the timely filing of applications by medical organizations and modification of the procurement module on the web portal of the Center for Electronic Finance JSC. According to the results of , units of medical equipment were purchased for a total amount of As a result of centralized procurement, it was possible to save 3. On the basis of the Single Distributor, a module for receiving applications for the purchase of medical equipment in the Unified Pharmaceutical Information System UPIS has been developed. In addition, at the moment, the Single Distributor is conducting a substantive study of the issues of localization of production with major global manufacturers in Korea, Japan, Europe and domestic manufacturers of medical equipment. During the report, the main effects of the ongoing work on the centralization of the purchase of medical equipment were announced - equipment in accordance with the level of medical care, updating the fleet of medical equipment, ensuring the achievement of indicators of National projects, improving service maintenance, equal access to medical care for the population of all regions of the country, reducing costs and budget savings. Previously, the Single Distributor prepared detailed material on the centralized procurement system and its stages, you can read it here. At the end of the meeting, an exchange of views took place, the meeting participants outlined the problematic aspects of drug supply from the prism of the public and voiced proposals for improving the drug supply system, which will be considered by the Single Distributor individually. The Chairman of the Board, in turn, thanked all the participants of the meeting for their interest, which helps to identify the pressing problems of the industry and noted the effectiveness of bilateral cooperation. It is worth noting that the Single Distributor site regularly raises questions from civil society, and openly discusses the pressing problems of drug provision of the population in order to make the necessary recommendations. A single distributor is open to direct dialogue and interaction, is set for close cooperation and constructive dialogue, so that each valuable proposal finds practical implementation and becomes a useful tool for improving the provision of medicines to Kazakhstanis. Back to news page. Contact center. Free of charge for all numbers. Public control. Acting Chairman's blog. Photo gallery. To see more.

Buying MDMA pills Aktobe